Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Perindopril
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : ZonMw
Deal Size : Inapplicable
Deal Type : Inapplicable
Timely Recovery After Subclinical Heart Failure
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 02, 2024
Lead Product(s) : Perindopril
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : ZonMw
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Perindopril
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 19, 2024
Lead Product(s) : Perindopril
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Perindopril
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 11, 2023
Lead Product(s) : Perindopril
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Perindopril
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : Servier
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Atorvastatin on Carotid Intima Media Thickness
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 13, 2020
Lead Product(s) : Perindopril
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : Servier
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Perindopril
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Phase II
Sponsor : Blueclinical
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 19, 2016
Lead Product(s) : Perindopril
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Phase II
Sponsor : Blueclinical
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Perindopril
Therapeutic Area : Endocrinology
Study Phase : Phase III
Sponsor : Servier
Deal Size : Inapplicable
Deal Type : Inapplicable
Perindopril vs Ramipril for Persistence in MAU Reduction Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 06, 2016
Lead Product(s) : Perindopril
Therapeutic Area : Endocrinology
Highest Development Status : Phase III
Sponsor : Servier
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Perindopril
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioequivalence Study of Two Formulations of Perindopril 4 mg Tablet Under Fasting Condition
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 11, 2012
Lead Product(s) : Perindopril
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Perindopril
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 09, 2010
Lead Product(s) : Perindopril
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable